Pfizer-BioNTech COVID-19 Vaccine
Jeneng umum: COVID-19 Vaccine, MRNA
Jeneng merek: Comirnaty
Bentuk dosis: suspensi kanggo injeksi intramuskular
Kelas obat:
Vaksin virus
Panganggone Pfizer-BioNTech COVID-19 Vaccine
Formula Vaksin COVID-19 Pfizer-BioNTech 2023-2024 (Vaksin COVID-19, mRNA) yaiku vaksin sing digawe dening Pfizer lan BioNTech sing bisa mbantu awak ngembangake kekebalan marang SARS-CoV-2, virus sing nyebabake COVID-19. Vaksin Pfizer-BioNTech COVID-19 minangka vaksin sing disetujoni FDA kanggo wong diwasa lan remaja umur 12 taun lan uga duwe ijin panggunaan darurat (EUA) kanggo bocah umur 6 wulan nganti 11 taun.
Vaksin sing dianyari iki ngemot protein spike kanggo sublineage XBB.1.5 saka SARS-CoV-2 lan uji coba wis nuduhake respon sing luwih apik marang pirang-pirang sublineage sing gegandhengan karo Omicron XBB, kalebu XBB.1.5, XBB.1.16, lan XBB.2.3, dibandhingake karo Omicron BA. .4/BA.5-dicocogake vaksin bivalent. Data pra-klinis uga nuduhake yen antibodi serum sing diakibatake dening vaksin sing dianyari 2023-2024 kanthi efektif netralake Omicron BA.2.86 (Pirola) lan subvarian EG.5.1 (Eris) sing ana hubungane karo Omicron sing dominan sacara global yen dibandhingake karo vaksin bivalent sadurunge. .
Kanggo individu sing sadurunge wis divaksinasi karo vaksin COVID-19, gunakake Vaksin COVID-19 Pfizer-BioNTech paling ora 2 wulan sawise dosis pungkasan vaksin COVID-19.
Formula Vaksin Pfizer-BioNTech COVID-19 2023-2024 dituduhake minangka dosis siji kanggo umume wong diwasa lan bocah umur 5 taun lan luwih. Bocah-bocah sing umure kurang saka 5 taun bisa uga layak nampa dosis tambahan vaksin iki yen durung ngrampungake seri telung dosis kanthi formulasi vaksin COVID-19 sadurunge.
Pfizer-BioNTech COVID-19 Vaksin (Formula 2023-2024) disetujoni dening FDA lan diwenehake EU tanggal 11 September 2023.
Pfizer-BioNTech COVID-19 Vaccine efek sisih
Vaksin Pfizer-BioNTech COVID-19 bisa nyebabake efek samping sing abot kalebu reaksi alergi. Reaksi alergi sing abot biasane kedadeyan sajrone sawetara menit nganti siji jam sawise njupuk dosis vaksin. Mulane, panyedhiya vaksinasi sampeyan bisa uga njaluk sampeyan tetep ing panggonan sampeyan nampa vaksin kanggo dipantau sawise vaksinasi.
Tandha-tandha reaksi alergi sing abot bisa uga kalebu:
Miokarditis lan perikarditis
Miokarditis (radang otot jantung) lan perikarditis (radang lapisan njaba jantung) minangka efek samping sing langka sing kedadeyan ing sawetara wong sing wis nampa vaksin. Umume, gejala wiwit ing sawetara dina sawise vaksin, lan gejala ditanggulangi kanthi manajemen konservatif. Sampeyan kudu langsung njaluk bantuan medis yen sampeyan duwe gejala ing ngisor iki sawise nampa vaksin:
Efek samping liyane sing umum kalebu:
Iki bisa uga ora kabeh efek samping saka vaksin kasebut. Efek samping sing serius lan ora dikarepke bisa kedadeyan.
Yen sampeyan ngalami reaksi alergi sing abot, hubungi 911, utawa menyang rumah sakit sing paling cedhak.
Telpon panyedhiya vaksinasi utawa panyedhiya kesehatan yen sampeyan duwe efek samping sing ngganggu utawa ora ilang.
Lapokake efek samping vaksin menyang Sistem Pelaporan Adverse Event (VAERS) Vaksin FDA/CDC. Nomer bebas pulsa VAERS yaiku 1-800-822-7967 utawa lapor online menyang https://vaers.hhs.gov/reportevent.html.
Sadurunge njupuk Pfizer-BioNTech COVID-19 Vaccine
Sampeyan ora kudu njaluk Vaksin Pfizer-BioNTech COVID-19 yen sampeyan nandhang reaksi alergi sing abot kanggo dosis sadurunge vaksin Pfizer-BioNTech COVID-19 (uga disebut Comirnaty) utawa komponen vaksin kasebut ( deleng "Bahan" ing ngisor iki).
Ora ana data sing cukup kanggo ngandhani wanita babagan risiko sing gegandhengan karo vaksin nalika meteng, nanging studi kewan sing winates banget ora nuduhake bukti mbebayani kanggo janin. Wanita meteng sing kena infeksi SARS-CoV-2 luwih beresiko kena COVID-19 abot dibandhingake karo wanita sing ora meteng.
Ora dingerteni apa Vaksin Pfizer-BioNTech COVID-19 diekskripsikake ing susu manungsa utawa efeke marang bayi sing disusui utawa produksi/ekskresi susu. Coba keuntungan lan risiko.
Safe lan efektifitas durung ditetepake ing bocah-bocah kurang saka 12 taun. Bukti saka studi klinis banget nuduhake manawa dosis siji Vaksin Pfizer-BioNTech COVID-19 ora efektif kanggo wong sing umure luwih enom tinimbang 6 wulan.
Related obat
- Abrysvo
- ACAM2000
- Adenovirus vaccine, live
- Afluria
- Afluria 2015-2016 Formula
- Afluria PF Pediatric Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2021-2022 injection
- Afluria PF Quadrivalent 2022-2023 injection
- Afluria PF Quadrivalent 2023-2024 injection
- Afluria Quadrivalent 2021-2022 injection
- Afluria Quadrivalent 2022-2023 injection
- Afluria Quadrivalent 2023-2024 injection
- Agriflu
- Arexvy
- Attenuvax
- Audenz
- Comirnaty
- Comirnaty (2023-2024) PF (cvx 309) 2023-2024
- COVID-19 (12y+) vaccine Spikevax 2023-2024
- COVID-19 (12y+) vaccine, Pfizer 2023-2024
- COVID-19 (5y-11y) vaccine, Pfizer 2023-2024
- COVID-19 (6m-11y) vaccine, Moderna 2023-2024
- COVID-19 (6m-4y) vaccine, Pfizer 2023-2024
- COVID-19 vaccine, Novavax (2023-2024)
- Mumps virus vaccine, live
- Mumpsvax
- Cervarix
- Dengue tetravalent vaccine, live
- Dengue vaccine
- Dengvaxia
- Dryvax
- Engerix-B
- Engerix-B (HepB)
- Engerix-B Pediatric
- Fluad
- Fluad 2017-2018 Formula
- Fluad Quadrivalent PF 2022-2023 injection
- Fluad Quadrivalent PF 2023-2024 injection
- Fluarix PF Quadrivalent 2021-2022 injection
- Fluarix PF Quadrivalent 2022-2023 injection
- Fluarix PF Quadrivalent 2023-2024 injection
- Fluarix Quadrivalent
- Fluarix Quadrivalent 2013-2014 Formula
- Fluarix Quadrivalent 2015-2016 Formula
- Flublok 2015-2016 Formula
- Flublok 2016-2017 Formula
- Flublok 2017-2018 Formula
- Flublok Quadrivalent
- Flublok Quadrivalent 2016-2017 Formula
- Flublok Quadrivalent 2017-2018 Formula
- Flublok Quadrivalent 2021-2022 injection
- Flublok Quadrivalent 2022-2023 injection
- Flublok Quadrivalent 2023-2024 injection
- Flucelvax 2015-2016 Formula
- Flucelvax PF Quadrivalent 2021-2022 injection
- Flucelvax PF Quadrivalent 2022-2023 injection
- Flucelvax PF Quadrivalent 2023-2024 injection
- Flucelvax Quadrivalent
- Flucelvax Quadrivalent 2021-2022 injection
- Flucelvax Quadrivalent 2022-2023 injection
- Flucelvax Quadrivalent 2023-2024 injection
- FluLaval PF Quadrivalent 2021-2022 injection
- FluLaval PF Quadrivalent 2022-2023 injection
- FluLaval PF Quadrivalent 2023-2024 injection
- Flulaval Quadravalent 2013-2014 Season
- FluLaval Quadrivalent
- FluLaval Quadrivalent 2015-2016 Formula
- Flumist
- FluMist Quadrivalent 2015-2016 Formula
- FluMist Quadrivalent 2023-2024 nasal
- Fluvirin 2015-2016 Formula
- Fluzone 2013-2014 Formula
- Fluzone 2015-2016 Formula
- Fluzone High Dose 2015-2016 Formula
- Fluzone High-Dose Quadrivalent PF 2021-2022 injection
- Fluzone High-Dose Quadrivalent PF 2022-2023 injection
- Fluzone High-Dose Quadrivalent PF 2023-2024 injection
- Fluzone Intradermal Quadrivalent 2014-2015 Formula
- Fluzone Intradermal Quadrivalent 2015-2016 Formula
- Fluzone PF Pediatric Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2021-2022 injection
- Fluzone PF Quadrivalent 2022-2023 injection
- Fluzone PF Quadrivalent 2023-2024 injection
- Fluzone Quadrivalent
- Fluzone Quadrivalent 2021-2022 injection
- Fluzone Quadrivalent 2022-2023 injection
- Fluzone Quadrivalent 2023-2024 injection
- Gardasil 9
- Gardasil 9 Vaccine
- Havrix
- Havrix Pediatric
- Hepatitis A adult vaccine
- Hepatitis A pediatric vaccine
- Hepatitis a vaccine
- Hepatitis B adult vaccine
- Hepatitis B pediatric vaccine
- Hepatitis b vaccine
- Hepatitis b vaccine recombinant, adjuvanted
- Heplisav-B
- Human papillomavirus (HPV) vaccine, 9-valent
- Human papillomavirus vaccine
- Imovax Rabies human diploid cell
- Influenza A (H1N1) 2009 Monovalent Vaccine
- Influenza a virus vaccine, h1n1, inactivated
- Influenza a virus vaccine, h5n1, adjuvanted
- Influenza virus vaccine
- Influenza virus vaccine injection
- Influenza virus vaccine nasal
- Influenza virus vaccine recombinant
- Influenza virus vaccine, adjuvanted
- Influenza Virus Vaccine, H5N1
- Influenza virus vaccine, live
- Ipol
- Ixiaro
- Janssen - Johnson & Johnson COVID-19 Vaccine
- Japanese encephalitis virus vaccine SA14-14-2
- Jynneos
- Measles virus vaccine, live
- Meruvax II
- Moderna COVID-19 (2023-2024) PF Vaccine (cvx 311) 2023-2024
- Moderna COVID-19 Vaccine
- Novavax COVID-19 (2023-2024) Vaccine,Adjuvanted PF (cvx 313)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) 2023-2024
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) 2023-2024
- Pfizer-BioNTech COVID-19 Vaccine
- Polio vaccine, inactivated
- Poliovirus vaccine, inactivated
- PreHevbrio
- RabAvert purified chick embryo cell
- Rabies vaccine human diploid cell
- Rabies vaccine purified chick embryo cell
- Recombivax HB
- Recombivax HB Adult
- Recombivax HB Dialysis Formulation
- Recombivax HB Pediatric/Adolescent
- Respiratory syncytial virus (RSV) vaccine
- Respiratory syncytial virus vaccine
- Respiratory syncytial virus vaccine, adjuvanted
- Rotarix
- Rotateq
- Rotavirus vaccine, live
- Rubella virus vaccine, live
- Sars-cov-2 (covid-19) vaccine, adenovirus 26 vector (janssen)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (moderna)
- Sars-cov-2 (covid-19) vaccine, mrna bivalent (pfizer)
- Sars-cov-2 (covid-19) vaccine, mrna-lnp, spike protein (moderna)
- Sars-cov-2 (covid-19) vaccine, protein subunit, adjuvanted (novavax)
- Shingrix
- Smallpox and monkeypox vaccine
- Smallpox monkeypox vaccine, live non-replicating
- Smallpox vaccine
- Spikevax
- Spikevax (2023-2024) PF (cvx 312) 2023-2024
- Tick-borne encephalitis pediatric vaccine
- Tick-borne encephalitis vaccine
- TicoVac
- TicoVac Pediatric
- Vaqta
- Vaqta Pediatric
- Varicella virus (chickenpox) vaccine
- Varicella virus vaccine, live
- Varivax
- Yellow fever vaccine
- YF-Vax
- Zostavax
- Zoster vaccine inactivated
- Zoster vaccine recombinant, adjuvanted
- Zoster vaccine, live
Carane nggunakake Pfizer-BioNTech COVID-19 Vaccine
Vaksin Pfizer-BioNTech COVID-19 diwenehake marang sampeyan minangka injeksi menyang otot, biasane otot deltoid ing lengen ndhuwur.
Pènget
Kontraindikasi kanggo wong sing nandhang reaksi alergi sing abot (kayata anafilaksis) marang komponen apa wae ing Vaksin Pfizer-BioNTech COVID-19.
Data postmarketing nuduhake yen ana peningkatan risiko miokarditis lan perikarditis, utamane ing minggu pisanan sawise vaksinasi. Resiko paling dhuwur kanggo Vaksin Pfizer-BioNTech COVID-19 yaiku ing wong lanang sing umure 12 taun nganti 17 taun.
Semaput bisa uga ana hubungane karo administrasi vaksin, kalebu Vaksin Pfizer-BioNTech COVID-19 . Marang panyedhiya kesehatan yen sampeyan cenderung pingsan lan njupuk langkah-langkah kanggo nglindhungi dhewe saka ciloko (kayata ngapusi).
Wong sing imunokompromi, kalebu individu sing nampa terapi imunosupresif, bisa uga kurang respon marang Pfizer. -Vaksin BioNTech COVID-19.
Apa obatan liyane bakal mengaruhi Pfizer-BioNTech COVID-19 Vaccine
Marang dhokter lan apoteker sampeyan babagan obat resep lan non-resep, vitamin, suplemen nutrisi, lan produk herbal sing sampeyan gunakake utawa rencana kanggo njupuk. Marang panyedhiya kesehatan yen sampeyan njupuk:
Uga, kandhani panyedhiya kesehatan yen sampeyan wis nampa vaksin COVID-19 liyane.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions